PCM
EW icon

Price Capital Management’s Edwards Lifesciences EW Stock Holding History

Price Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,600
Closed -$228K – 81
2015
Q1 		$228K Buy
+9,600
New +$215K 0.14% 238

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Price Capital Management's EW Position: Q2 2015 in Review

Price Capital Management sold out of Edwards Lifesciences (EW) in Q2 2015, closing a stake of 9,600 shares — an estimated $228K sold.

Price Capital Management first reported a position in EW in Q1 2015 and held it in 1 quarter. The position peaked at $228K in Q1 2015. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

  • Price Capital Management reported no remaining Edwards Lifesciences position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 9,600 Edwards Lifesciences shares in Q2 2015, an estimated $228K.
  • Price Capital Management first reported a position in Edwards Lifesciences in Q1 2015 and held it in 1 quarter.
  • Price Capital Management's Edwards Lifesciences position peaked at $228K in Q1 2015.
  • 579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.